We are live on ! Find out more
UONDDL

University of Notre Dame du Lac Portfolio holdings

AUM $66.8M
1-Year Est. Return 43.52%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+43.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$359M
AUM Growth
+$20.7M
Cap. Flow
+$1.87M
Cap. Flow %
0.52%
Top 10 Hldgs %
29.12%
Holding
89
New
16
Increased
33
Reduced
20
Closed
18

Top Buys

Rank Stock Value
1
IMMR icon
Immersion
IMMR
+$5.57M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.37M
3
BABA icon
Alibaba
BABA
+$4.99M
4
VRNS icon
Varonis Systems
VRNS
+$4.97M
5
AXTA icon
Axalta
AXTA
+$4.95M

Sector Composition

Rank Sector Weight
1 Healthcare 23.71%
2 Financials 18.28%
3 Communication Services 13.21%
4 Technology 11.32%
5 Consumer Discretionary 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
51
BeOne Medicines Ltd
ONC
$40.6B
$3.68M 1.03%
35,603
-29,851
-46% -$2.22M
EPZM
52
DELISTED
Epizyme, Inc
EPZM
$3.65M 1.02%
191,719
+38,368
+25% +$585K
NKTR icon
53
Nektar Therapeutics
NKTR
$2.57B
$3.16M 0.88%
8,784
+475
+6% +$149K
SGEN
54
DELISTED
Seagen Inc. Common Stock
SGEN
$3.01M 0.84%
55,319
+16,024
+41% +$820K
CLVS
55
DELISTED
Clovis Oncology, Inc.
CLVS
$3.01M 0.84%
36,529
-14,366
-28% -$1.14M
VNDA icon
56
Vanda Pharmaceuticals
VNDA
$314M
$2.82M 0.79%
+157,781
New +$2.64M
AMRN
57
Amarin Corp
AMRN
$297M
$2.81M 0.78%
+40,194
New +$2.85M
ABMD
58
DELISTED
Abiomed Inc
ABMD
$2.78M 0.77%
16,467
-1,888
-10% -$285K
NGNE icon
59
Neurogene
NGNE
$738M
$2.7M 0.75%
9,514
+953
+11% +$274K
GHDX
60
DELISTED
Genomic Health, Inc.
GHDX
$2.65M 0.74%
82,503
+2,368
+3% +$74.7K
ZBH icon
61
Zimmer Biomet
ZBH
$18.7B
$2.64M 0.74%
+23,255
New +$2.68M
AET
62
DELISTED
Aetna Inc
AET
$2.6M 0.72%
+16,318
New +$2.55M
DBVT
63
DBV Technologies
DBVT
$889M
$2.52M 0.7%
5,926
-1,128
-16% -$483K
AKAO
64
DELISTED
Achaogen Inc
AKAO
$2.48M 0.69%
155,654
+51,786
+50% +$985K
HUM icon
65
Humana
HUM
$46.7B
$2.47M 0.69%
10,151
-532
-5% -$130K
LH icon
66
Labcorp
LH
$26.2B
$2.45M 0.68%
18,893
-1,556
-8% -$208K
INCY icon
67
Incyte
INCY
$24.5B
$2.35M 0.65%
20,116
-21,962
-52% -$2.78M
UTHR icon
68
United Therapeutics
UTHR
$21.9B
$2.3M 0.64%
19,588
-475
-2% -$60.7K
EVHC
69
DELISTED
Envision Healthcare Holdings Inc
EVHC
$2.23M 0.62%
49,498
-67,752
-58% -$3.61M
SAGE
70
DELISTED
Sage Therapeutics
SAGE
$1.88M 0.52%
30,144
-4,792
-14% -$376K
VNQ icon
71
Vanguard Real Estate ETF
VNQ
$38.6B
$1.31M 0.37%
15,815
+162
+1% +$13.5K
AAPL icon
72
Apple
AAPL
$4.41T
-109,472
Closed -$3.94M
ADSK icon
73
Autodesk
ADSK
$52.7B
-44,098
Closed -$4.45M
BCRX icon
74
BioCryst Pharmaceuticals
BCRX
$2.71B
-422,767
Closed -$2.35M
BKNG icon
75
Booking.com
BKNG
$159B
-58,725
Closed -$4.39M

Similar funds

University of Notre Dame du Lac's Q3 2017 Portfolio in Review

As of Q3 2017, University of Notre Dame du Lac held 89 positions worth $359M, up 6.1% from $338M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

University of Notre Dame du Lac's Q3 2017 filing shows 16 new, 33 increased, 20 reduced and 18 closed positions. Its largest new stake was Immersion: 711,122 shares worth $5.81M. The largest sale was Charter Communications, an estimated $5.99M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 27% a quarter earlier, followed by Financials and Communication Services.

  • University of Notre Dame du Lac's largest Q3 2017 buy was Immersion: 711,122 shares worth $5.81M.
  • University of Notre Dame du Lac added most to Alphabet (Google) Class C in Q3 2017, an estimated $5.37M increase.
  • University of Notre Dame du Lac's biggest Q3 2017 reduction was Charter Communications, cutting an estimated $5.99M.
  • University of Notre Dame du Lac fully exited Impinj in Q3 2017, selling an estimated $4.9M.
  • University of Notre Dame du Lac's ten largest holdings make up 29% of its $359M portfolio in Q3 2017.
  • University of Notre Dame du Lac opened 16 new positions and closed 18 in Q3 2017.
  • University of Notre Dame du Lac's portfolio value rose 6.1% quarter-over-quarter to $359M.

Based on University of Notre Dame du Lac's 13F filing for Q3 2017, filed 13 Nov 2017.